// Renal/Genitourinary System - Drugs
// Auto-generated from modularize-data.js

const drugs = [

    {
        "id": "torsemide",
        "name": "Torsemide",
        "pharmacologicClass": "loop-diuretics",
        "therapeuticClass": "diuretics",
        "systems": ["renal-genitourinary-system", "cardiovascular-system"],
        "mechanism": "Inhibit NKCC2 transporter in thick ascending limb of loop of Henle.",
        "features": "Longer half-life, better bioavailability.",
        "clinicalChoice": "Heart failure with poor oral absorption.",
        "indications": [
            "Heart Failure",
            "Hypertension"
        ],
        "contraindications": [
            "Anuria",
            "Sulfonamide Allergy"
        ],
        "sideEffects": [
            "Hypokalemia",
            "Hyponatremia",
            "Ototoxicity",
            "Hyperuricemia"
        ],
        "interactions": "Aminoglycosides (increased ototoxicity), lithium (increased levels).",
        "interactionDetails": "AMINOGLYCOSIDES: MECHANISM - Both loop diuretics and aminoglycosides have direct ototoxic effects on hair cells in the cochlea. Loop diuretics may increase aminoglycoside concentration in the inner ear. CONSEQUENCE - Synergistic ototoxicity leading to permanent hearing loss, especially high-frequency hearing. LITHIUM: MECHANISM - Loop diuretics cause volume depletion, leading to increased proximal tubule lithium reabsorption. CONSEQUENCE - Elevated lithium levels with risk of lithium toxicity including tremor, confusion, and nephrotoxicity.",
        "highYield": true,
        "pageType": "drug"
    },
    {
        "id": "indapamide",
        "name": "Indapamide",
        "pharmacologicClass": "thiazide-diuretics",
        "therapeuticClass": "diuretics",
        "systems": ["renal-genitourinary-system", "cardiovascular-system"],
        "mechanism": "Inhibit NCC transporter in distal convoluted tubule.",
        "features": "Less metabolic side effects.",
        "clinicalChoice": "Diabetes with hypertension.",
        "indications": [
            "Hypertension"
        ],
        "contraindications": [
            "Anuria",
            "Sulfonamide Allergy"
        ],
        "sideEffects": [
            "Hypokalemia",
            "Hyperuricemia",
            "Hyperglycemia",
            "Hyperlipidemia"
        ],
        "interactions": "Lithium (increased levels), NSAIDs (reduced efficacy).",
        "interactionDetails": "LITHIUM: MECHANISM - Thiazides cause mild volume depletion, increasing proximal tubule sodium and lithium reabsorption. CONSEQUENCE - Increased lithium levels with risk of toxicity. NSAIDS: MECHANISM - Thiazides work partly through prostaglandin-mediated vasodilation. NSAIDs inhibit prostaglandin synthesis. CONSEQUENCE - Reduced antihypertensive efficacy and potential for acute kidney injury.",
        "highYield": true,
        "pageType": "drug"
    },
    {
        "id": "amiloride",
        "name": "Amiloride",
        "pharmacologicClass": "potassium-sparing-diuretics",
        "therapeuticClass": "diuretics",
        "systems": ["renal-genitourinary-system", "cardiovascular-system"],
        "mechanism": "Either block aldosterone receptors (spironolactone) or ENaC channels (amiloride).",
        "features": "ENaC channel blocker.",
        "clinicalChoice": "Hypertension without hormonal effects.",
        "indications": [
            "Hypertension",
            "Edema"
        ],
        "contraindications": [
            "Hyperkalemia",
            "Anuria"
        ],
        "sideEffects": [
            "Hyperkalemia",
            "Gynecomastia (spironolactone)",
            "Menstrual irregularities"
        ],
        "interactions": "ACE inhibitors, ARBs (hyperkalemia risk).",
        "interactionDetails": "ACE INHIBITORS/ARBS: MECHANISM - ACE inhibitors and ARBs reduce aldosterone production, leading to potassium retention. Potassium-sparing diuretics independently block potassium excretion. CONSEQUENCE - Additive hyperkalemia with risk of fatal cardiac arrhythmias, especially in patients with kidney disease or diabetes.",
        "highYield": true,
        "pageType": "drug"
    },
    {
        "id": "acetazolamide",
        "name": "Acetazolamide",
        "pharmacologicClass": "carbonic-anhydrase-inhibitors",
        "therapeuticClass": "diuretics",
        "system": "renal-genitourinary-system",
        "mechanism": "Inhibit carbonic anhydrase in proximal tubule, reducing sodium reabsorption.",
        "features": "Weak diuretic, crosses blood-brain barrier.",
        "clinicalChoice": "Glaucoma, altitude sickness.",
        "indications": [
            "Glaucoma",
            "Altitude Sickness",
            "Epilepsy"
        ],
        "contraindications": [
            "Sulfonamide Allergy",
            "Severe Renal Disease"
        ],
        "sideEffects": [
            "Metabolic acidosis",
            "Hypokalemia",
            "Kidney stones"
        ],
        "interactions": "Salicylates (increased toxicity).",
        "interactionDetails": "SALICYLATES: MECHANISM - Both carbonic anhydrase inhibitors and salicylates can cause metabolic acidosis. Acetazolamide may also increase salicylate levels by altering renal elimination. CONSEQUENCE - Enhanced salicylate toxicity with confusion, tinnitus, and potentially fatal metabolic acidosis.",
        "highYield": true,
        "pageType": "drug"
    },
    {
        "id": "mannitol",
        "name": "Mannitol",
        "pharmacologicClass": "osmotic-diuretics",
        "therapeuticClass": "diuretics",
        "system": "renal-genitourinary-system",
        "mechanism": "Increase tubular fluid osmolarity, drawing free water out of tissues and into filtrate.",
        "features": "IV sugar alcohol, does not cross BBB.",
        "clinicalChoice": "Increased intracranial or intraocular pressure.",
        "indications": [
            "Cerebral Edema",
            "Acute Glaucoma",
            "Drug Overdose"
        ],
        "contraindications": [
            "Anuria",
            "Heart Failure",
            "Pulmonary Edema"
        ],
        "sideEffects": [
            "Pulmonary edema",
            "Dehydration",
            "Hypernatremia"
        ],
        "interactions": "Additive nephrotoxicity with other nephrotoxic agents.",
        "interactionDetails": "",
        "highYield": true,
        "pageType": "drug"
    },
    {
        "id": "finasteride",
        "name": "Finasteride",
        "pharmacologicClass": "5α-reductase-inhibitors",
        "therapeuticClass": "benign-prostatic-hyperplasia-bph",
        "system": "renal-genitourinary-system",
        "mechanism": "Inhibit conversion of testosterone to dihydrotestosterone (DHT), reducing prostate size.",
        "features": "Inhibits type II 5α-reductase.",
        "clinicalChoice": "BPH with enlarged prostate, male pattern baldness.",
        "indications": [
            "Benign Prostatic Hyperplasia",
            "Male Pattern Baldness"
        ],
        "contraindications": [
            "Pregnancy",
            "Women of Childbearing Age"
        ],
        "sideEffects": [
            "Decreased libido",
            "Erectile dysfunction",
            "Gynecomastia"
        ],
        "interactions": "Minimal drug interactions.",
        "interactionDetails": "",
        "highYield": true,
        "pageType": "drug"
    },
    {
        "id": "dutasteride",
        "name": "Dutasteride",
        "pharmacologicClass": "5α-reductase-inhibitors",
        "therapeuticClass": "benign-prostatic-hyperplasia-bph",
        "system": "renal-genitourinary-system",
        "mechanism": "Inhibit conversion of testosterone to dihydrotestosterone (DHT), reducing prostate size.",
        "features": "Inhibits both type I and II 5α-reductase.",
        "clinicalChoice": "BPH with faster symptom improvement.",
        "indications": [
            "Benign Prostatic Hyperplasia"
        ],
        "contraindications": [
            "Pregnancy",
            "Women of Childbearing Age"
        ],
        "sideEffects": [
            "Decreased libido",
            "Erectile dysfunction",
            "Gynecomastia"
        ],
        "interactions": "Minimal drug interactions.",
        "interactionDetails": "",
        "highYield": true,
        "pageType": "drug"
    },
    {
        "id": "nitrofurantoin",
        "name": "Nitrofurantoin",
        "pharmacologicClass": "urinary-antiseptics",
        "therapeuticClass": "urinary-tract-infections",
        "system": "renal-genitourinary-system",
        "mechanism": "Concentrated in urine to achieve bactericidal levels in urinary tract.",
        "features": "Concentrated in urine, minimal systemic absorption.",
        "clinicalChoice": "Uncomplicated cystitis, UTI prophylaxis.",
        "indications": [
            "Uncomplicated UTI",
            "UTI Prophylaxis"
        ],
        "contraindications": [
            "Severe Renal Impairment",
            "G6PD Deficiency"
        ],
        "sideEffects": [
            "GI upset",
            "Pulmonary toxicity (nitrofurantoin)",
            "Hemolysis in G6PD deficiency"
        ],
        "interactions": "Antacids (reduced absorption).",
        "interactionDetails": "",
        "highYield": true,
        "pageType": "drug"
    },
    {
        "id": "desmopressin-ddavp",
        "name": "Desmopressin (DDAVP)",
        "pharmacologicClass": "adh-agonists",
        "therapeuticClass": "adh-related-disorders",
        "system": "renal-genitourinary-system",
        "mechanism": "Activate V2 receptors in collecting duct, increasing water reabsorption.",
        "features": "Synthetic ADH analog with longer duration.",
        "clinicalChoice": "Central diabetes insipidus, nocturnal enuresis.",
        "indications": [
            "Central Diabetes Insipidus",
            "Nocturnal Enuresis",
            "Hemophilia A"
        ],
        "contraindications": [
            "Hyponatremia",
            "Severe Renal Impairment"
        ],
        "sideEffects": [
            "Hyponatremia",
            "Water intoxication",
            "Headache"
        ],
        "interactions": "NSAIDs (potentiate ADH effects).",
        "interactionDetails": "",
        "highYield": true,
        "pageType": "drug"
    },
    {
        "id": "tolvaptan",
        "name": "Tolvaptan",
        "pharmacologicClass": "adh-antagonists",
        "therapeuticClass": "adh-related-disorders",
        "system": "renal-genitourinary-system",
        "mechanism": "Block V2 receptors, promoting free water excretion.",
        "features": "Oral V2 receptor antagonist.",
        "clinicalChoice": "SIADH, hyponatremia.",
        "indications": [
            "SIADH",
            "Hyponatremia"
        ],
        "contraindications": [
            "Hypernatremia",
            "Inability to Sense Thirst"
        ],
        "sideEffects": [
            "Hypernatremia",
            "Dehydration",
            "Thirst"
        ],
        "interactions": "CYP3A4 inhibitors (increased levels).",
        "interactionDetails": "",
        "highYield": true,
        "pageType": "drug"
    },
    {
        "id": "tamsulosin",
        "name": "Tamsulosin",
        "pharmacologicClass": "alpha-1-blockers",
        "therapeuticClass": "benign-prostatic-hyperplasia-bph",
        "systems": ["renal-genitourinary-system", "cardiovascular-system"],
        "mechanism": "Selectively block alpha-1A receptors in prostate and bladder neck, relaxing smooth muscle and improving urinary flow.",
        "features": "Highly selective for alpha-1A (prostate > vascular), less orthostatic hypotension than non-selective alpha-blockers.",
        "clinicalChoice": "First-line for BPH with LUTS (lower urinary tract symptoms), rapid symptom relief.",
        "indications": [
            "Benign Prostatic Hyperplasia (BPH)",
            "Ureteral Stones (off-label - facilitates passage)"
        ],
        "contraindications": [
            "Hypersensitivity to tamsulosin",
            "Severe Hepatic Impairment"
        ],
        "sideEffects": [
            "Orthostatic hypotension (less than non-selective)",
            "Dizziness",
            "Retrograde ejaculation (common, 10-18%)",
            "Intraoperative floppy iris syndrome (cataract surgery)",
            "Rhinitis",
            "Asthenia"
        ],
        "interactions": "Other alpha-blockers (additive hypotension), PDE5 inhibitors (hypotension), strong CYP3A4 inhibitors (increased levels).",
        "interactionDetails": "PDE5 INHIBITORS: MECHANISM - Both tamsulosin and PDE5 inhibitors (sildenafil, tadalafil) cause vasodilation. Tamsulosin via alpha-blockade, PDE5 inhibitors via cGMP. CONSEQUENCE - Additive hypotension, especially orthostatic. Use lowest doses, monitor blood pressure. CYP3A4 INHIBITORS: MECHANISM - Tamsulosin metabolized by CYP3A4 and CYP2D6. Strong CYP3A4 inhibitors (ketoconazole, clarithromycin) increase tamsulosin levels. CONSEQUENCE - Enhanced alpha-blockade, increased hypotension and side effects. Avoid strong CYP3A4 inhibitors or reduce tamsulosin dose.",
        "highYield": true,
        "pageType": "drug"
    },
    {
        "id": "terazosin",
        "name": "Terazosin",
        "pharmacologicClass": "alpha-1-blockers",
        "therapeuticClass": "benign-prostatic-hyperplasia-bph",
        "systems": ["renal-genitourinary-system", "cardiovascular-system"],
        "mechanism": "Non-selective alpha-1 blocker (alpha-1A, alpha-1B, alpha-1D) that relaxes smooth muscle in prostate, bladder neck, and blood vessels.",
        "features": "Non-selective alpha-1 blocker, requires dose titration, also effective for hypertension.",
        "clinicalChoice": "BPH with concurrent hypertension (dual benefit), alternative if tamsulosin not tolerated.",
        "indications": [
            "Benign Prostatic Hyperplasia (BPH)",
            "Hypertension"
        ],
        "contraindications": [
            "Hypersensitivity to terazosin or quinazolines"
        ],
        "sideEffects": [
            "Orthostatic hypotension (first-dose phenomenon - common)",
            "Dizziness",
            "Asthenia",
            "Retrograde ejaculation",
            "Headache",
            "Peripheral edema",
            "Syncope"
        ],
        "interactions": "Antihypertensives (additive hypotension), PDE5 inhibitors (hypotension).",
        "interactionDetails": "ANTIHYPERTENSIVES: MECHANISM - Terazosin causes vasodilation via alpha-1 blockade. Additive with other blood pressure lowering drugs. CONSEQUENCE - Severe orthostatic hypotension, especially first dose. Start low dose at bedtime, titrate slowly. PDE5 INHIBITORS: MECHANISM - Additive vasodilation (alpha-blockade + increased cGMP). CONSEQUENCE - Significant hypotension. Avoid concurrent use if possible, or use lowest doses with close monitoring.",
        "highYield": true,
        "pageType": "drug"
    }

];export default drugs;
